18 related articles for article (PubMed ID: 38457838)
1. Three scans are better than two for follow-up: An automatic method for finding missed and misidentified lesions in cross-sectional follow-up of oncology patients.
Joskowicz L; Di Veroli B; Lederman R; Shoshan Y; Sosna J
Eur J Radiol; 2024 Jul; 176():111530. PubMed ID: 38810439
[TBL] [Abstract][Full Text] [Related]
2. Global image registration using a symmetric block-matching approach.
Modat M; Cash DM; Daga P; Winston GP; Duncan JS; Ourselin S
J Med Imaging (Bellingham); 2014 Jul; 1(2):024003. PubMed ID: 26158035
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a longitudinal soft-tissue metastatic lesion matching algorithm.
Santoro-Fernandes V; Huff D; Scarpelli ML; Perk TG; Albertini MR; Perlman S; Yip SSF; Jeraj R
Phys Med Biol; 2021 Jul; 66(15):. PubMed ID: 34261045
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.
Al-Nabhani KZ; Syed R; Michopoulou S; Alkalbani J; Afaq A; Panagiotidis E; O'Meara C; Groves A; Ell P; Bomanji J
J Nucl Med; 2014 Jan; 55(1):88-94. PubMed ID: 24337608
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of
Sawicki LM; Deuschl C; Beiderwellen K; Ruhlmann V; Poeppel TD; Heusch P; Lahner H; Führer D; Bockisch A; Herrmann K; Forsting M; Antoch G; Umutlu L
Eur Radiol; 2017 Oct; 27(10):4091-4099. PubMed ID: 28439648
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
7. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
[TBL] [Abstract][Full Text] [Related]
8. An automated methodology for whole-body, multimodality tracking of individual cancer lesions.
Santoro-Fernandes V; Huff DT; Rivetti L; Deatsch A; Schott B; Perlman SB; Jeraj R
Phys Med Biol; 2024 Apr; 69(8):. PubMed ID: 38457838
[No Abstract] [Full Text] [Related]
9. Multimodality Imaging of Neuroendocrine Tumors.
Galgano SJ; Sharbidre K; Morgan DE
Radiol Clin North Am; 2020 Nov; 58(6):1147-1159. PubMed ID: 33040854
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
